Navigation Links
Oramed Pharmaceuticals Announces Successful Results of a Novel Exploratory Clinical Study of its Flagship Oral Insulin Capsule
Date:9/14/2010

printinclude-->

Oramed Pharmaceuticals Announces Successful Results of a Novel Exploratory Clinical Study of its Flagship Oral Insulin Capsule

   

Proof of Concept Study for a New Indication of Oral Insulin Capsule for Type 1 Diabetics

JERUSALEM, September 14, 2010 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) announced today successful results in an exploratory clinical trial testing the effectiveness of its oral insulin capsule (ORMD-0801) in Type I diabetes patients suffering from uncontrolled diabetes.

In parallel to Oramed's main focus in developing an oral insulin capsule for management of Type II diabetes the company is exploring an application of its oral insulin capsule toward cases of uncontrolled Type I diabetics. Unstable or labile diabetes is characterized by recurrent, unpredictable and dramatic blood glucose swings often linked with irregular hyperglycemia and sometimes serious hypoglycemia affecting Type I diabetes patients. This newly completed exploratory study was a proof of concept study for defining a novel indication for ORMD-0801. The encouraging results justify further clinical development of ORMD-0801 capsule application toward management of uncontrolled diabetes.

"This study marks an impressive milestone for Oramed," says Nadav Kidron, CEO of Oramed Pharmaceuticals. "These results suggest a possible novel and unique indication for our oral insulin product in the treatment of Type I diabetes in addition to our main indication for Type II diabetes."

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in Phase 2 clinical trials.
'/>"/>

SOURCE Oramed Pharmaceticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
2. Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association
3. Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd.
4. Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D.
5. Oramed Pharmaceuticals Announces Filing of Two Registration Statements
6. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
7. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
8. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
9. Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
10. Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA)
11. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... DIEGO , Sept. 18, 2014  Halozyme ... announced that the U.S. Food and Drug Administration ... enrollment and dosing of PEGPH20 in SWOG,s ongoing ... designed to evaluate Halozyme,s investigational drug PEGPH20 (PEGylated ... chemotherapy (mFOLFIRINOX) in patients with metastatic pancreatic adenocarcinoma.  ...
(Date:9/18/2014)... -- Australian biomarker discovery company Minomic International Ltd will ... prostate cancer screening test, planning to achieve US Food ... Minomic,s proprietary MiStat™ technology is a screening assay ... known as the MIL-38 antigen. This biomarker is present ... Researchers at 11 leading urology centres in ...
(Date:9/18/2014)... , Sept. 18, 2014 /CNW/ - A new expert panel ... Canada , released today by the Council ... and effective medicines for children. Each year about half ... use at least one prescription drug. Much of this ... the authorized use), creating potential health risks. ...
Breaking Medicine Technology:SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 2SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 4Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 3
... , BEDFORD, Mass., Aug. 19 Holo ... (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of ... healthcare needs of women, today announced the publication of the first of ... both symptomatic and asymptomatic pregnant women at risk for preterm birth. The ...
... , JAMESBURG, N.J., Aug. 19 Phytomedics Inc. today ... 2b clinical trial with an extract of Tripterygium wilfordii Hook F ... in the August 18, 2009 issue of the Annals of Internal ... article entitled "Comparison of Tripterygium wilfordii Hook F versus ...
Cached Medicine Technology:Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 2Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 3Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 4Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis 2Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis 3
(Date:9/18/2014)... Texas Physical Therapy Specialists (TexPTS) is proud ... Physicians Association (HPA) Friends and Family Golf tournament ... The tournament, which will take place at TopGolf from ... scholarships through three golf challenges, “Top Scramble”, “Top Score”, ... is provided at the event and there will be ...
(Date:9/18/2014)... 18, 2014 After years of shooting at ... firing range berms were saturated with lead, which increased the ... in the berm and send metal fragments back at the ... splashback, and the greater the potential for injury to officers. ... to remove lead from the range environment. , ...
(Date:9/18/2014)... 18, 2014 Sutter Health’s California Pacific ... of Dolby Laboratories, by naming the Ray Dolby Brain ... Ray Dolby provided a founding gift of $21 million ... provides services to patients and families suffering from Alzheimer’s, ... have been treated at the center since its opening ...
(Date:9/18/2014)... On August 23, the HearStrong Foundation ... Service Award for his contributions to the deaf and ... Retired Players Association (NBRPA) Legends World Sports Conference in ... in 1977, Glenn would go on to play for ... Hawks, and the Milwaukee Bucks throughout his ten-year career ...
(Date:9/18/2014)... MD Complete , the breakthrough ... prescription, announced today that SHAPE Magazine has named ... Peel” in its annual Beauty Awards. The issue is ... products as tested by SHAPE’s expert team. , SHAPE ... Among the thousands of beauty products launched every year, ...
Breaking Medicine News(10 mins):Health News:Texas Physical Therapy Specialists Sponsoring HPA Friends & Family Golf Tournament 2Health News:Firing Range Safety is Ohio DOC Priority 2Health News:Firing Range Safety is Ohio DOC Priority 3Health News:Sutter Health’s CPMC announces Ray Dolby Brain Health Center 2Health News:Sutter Health’s CPMC announces Ray Dolby Brain Health Center 3Health News:The HearStrong Foundation Recognizes Mike “Stinger” Glenn with the Distinguished Service Award at the 2014 Legends World Sports Conference 2Health News:The HearStrong Foundation Recognizes Mike “Stinger” Glenn with the Distinguished Service Award at the 2014 Legends World Sports Conference 3Health News:MD Complete Wins Shape Beauty Award for Best Peel 2
... Accounts; Membership in ECP Global Communication International NetworkNEW ... www.feintuchcommunications.com ), a strategic relations firm ... Feintuch, has opened for business with offices at ... http://www.newscom.com/cgi-bin/prnh/20090406/NY94367LOGO )Mr. ...
... for Medical Benefits, Movement to Direct Contracting for ... HealthLeaders-InterStudyNASHVILLE, Tenn., April 6 HealthLeaders-InterStudy, the leading ... between January 2008 and July 2008 enrollment in ... with a pharmacy benefit manager (PBM), also known ...
... Michael Paddock, CEO of Grants Office, LLC and a ... for on-camera and telephone interviews.Over the past several months, ... of knowledge and resources relating to the American Recovery ... knowledge of the various facets of ARRA funding (in ...
... April 6 The Quantum Group, Inc. (NYSE Amex: ... a Healthcare Services Organization (HSO), announced today that PWeR(TM) ... information platform and IBM hosted solution, is presenting in ... and Management Systems Society) Conference. The HIMSS09 conference ...
... those diagnosed with autism have underlying medical disorders that ... improvementATLANTA, April 6 A child is diagnosed with ... is more common in American children than cancer, diabetes, ... Control (CDC) estimates that one in every 94 boys ...
... Breakthrough Study Led by USC and Mayo ... Older adults can significantly improve their memory and performance ... according to a study published today in The Journal ... of 487 healthy older adults was led by researchers ...
Cached Medicine News:Health News:Feintuch Communications Launches as Independent Strategic Relations Firm 2Health News:Feintuch Communications Launches as Independent Strategic Relations Firm 3Health News:Feintuch Communications Launches as Independent Strategic Relations Firm 4Health News:Enrollment in Employer-Contracted Pharmacy Benefit 'Carve-Out' Increased by More than Six Million Lives 2Health News:Grants Office CEO Available for Media Interviews on Stimulus Funding 2Health News:PWeR(TM) Presenting at HIMSS Conference in Chicago 2Health News:PWeR(TM) Presenting at HIMSS Conference in Chicago 3Health News:PWeR(TM) Presenting at HIMSS Conference in Chicago 4Health News:Alarming Rise in Autism Brings Hundreds of Parents, Researchers and Clinicians Together from Around the World to Atlanta April 17-19, 2009 2Health News:Computerized Brain Exercise Improves Memory 2
Inquire...
... The Trinity Biotech Captia™ Mumps IgG ... the detection and quantitative determination of IgG ... Individual serum specimens may be used for ... acute and convalescent, may be used to ...
... AUTOMATION, INC. (DAI) Mumps IgG ... intended for the detection and ... to Mumps virus in human ... be used for the determination ...
... Corporation announced the launch of the ... first bi-directional cooled-tip catheter available in the ... offers physicians the benefits of cooled ablation ... the Boston Scientific Blazer(R) catheter platform. ,Cooled ...
Medicine Products: